Similar articles

• Somatostatin and counterregulatory hormone responses to hypoglycaemia in diabetics with and without autonomic neuropathy.

  Fernandez-Castaner M, Webb S, Levy I, Rios M, Casamitjana R, Bergua M, Figuerola D, Rivera F. Fernandez-Castaner M, et al. Diabete Metab. 1985 Apr;11(2):81-6. Diabete Metab. 1985. PMID: 2861121
• Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy.

  Horie H, Hanafusa T, Matsuyama T, Namba M, Nonaka K, Tarui S, Yamatodani A, Wada H. Horie H, et al. Horm Metab Res. 1984 Aug;16(8):398-401. doi: 10.1055/s-2007-1014802. Horm Metab Res. 1984. PMID: 6381272
• Increased metabolic sensitivity towards adrenaline in diabetic autonomic neuropathy.

  Hilsted J, Richter EA, Madsbad S, Tronier B, Christensen NJ, Hildebrandt P, Galbo H, Damkjaer M. Hilsted J, et al. Clin Physiol. 1985;5 Suppl 5:72-3. Clin Physiol. 1985. PMID: 2870836 No abstract available.
• Hormonal secretion in diabetic autonomic neuropathy.

  Vinik AI, Glowniak JV. Vinik AI, et al. N Y State J Med. 1982 May;82(6):871-86. N Y State J Med. 1982. PMID: 6124920 Review. No abstract available.
• The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus.

  Cryer PE, White NH, Santiago JV. Cryer PE, et al. Endocr Rev. 1986 May;7(2):131-9. doi: 10.1210/edrv-7-2-131. Endocr Rev. 1986. PMID: 2873031 Review. No abstract available.